GYRE · Gyre Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| GNI Group Ltd. | ▼ Sell | Other | 64,005,887 Shares held | 10/30/2023 | View profile |
| Ma Songjiang President | ▼ Sell | Open Market | 2,806,084 Shares held | 5/28/2025 | View profile |
| Luo Ying | ▼ Sell | Open Market | 2,565,226 Shares held | 5/6/2026 | View profile |
| Ye Weiguo Chief Operating Officer | ▼ Sell | Open Market | 700,000 Shares held | 6/18/2026 | View profile |
| Eddie Williams Director | ▲ Buy | Grant | 34,804 Shares held | 1/7/2022 | View profile |
| Ling Geoffrey M.D. Director | ▲ Buy | Grant | 31,790 Shares held | 1/7/2022 | View profile |
| Errol B. Desouza Director | ▲ Buy | Grant | 29,801 Shares held | 10/1/2021 | View profile |
| Eastling Thomas Wilson | ▲ Buy | Option Exercise | 15,000 Shares held | 4/16/2025 | View profile |
| Blouse Grant E. Chief Scientific Officer | ▲ Buy | Open Market | 9,417 Shares held | 8/9/2022 | View profile |
| USMAN NASSIM President & CEO | ▼ Sell | Open Market | 1,636 Shares held | 6/28/2024 | View profile |
| LAWLOR AUGUSTINE Director | ▼ Sell | Other | 0 Shares held | 8/31/2023 | View profile |
| GNI Hong Kong Ltd | ▼ Sell | Other | 0 Shares held | 10/27/2023 | View profile |
| Miller Seline E. SVP Finance; Interim CFO & PAO | ▼ Sell | Other | 0 Shares held | 8/31/2023 | View profile |
| Hunt Andrea Director | ▼ Sell | Other | 0 Shares held | 8/31/2023 | View profile |
Transaction History
| Ye Weiguo | ▼ Sell | Open Market | 3,000 | $19K | 6/18/2026 |
| Ye Weiguo | ▲ Buy | Option Exercise | 3,000 | $2K | 6/18/2026 |
| Ye Weiguo | ▼ Sell | Open Market | 2,800 | $17K | 6/11/2026 |
| Ye Weiguo | ▲ Buy | Option Exercise | 2,800 | $2K | 6/11/2026 |
| Ye Weiguo | ▲ Buy | Option Exercise | 6,418 | $5K | 6/10/2026 |
| Ye Weiguo | ▼ Sell | Open Market | 6,418 | $40K | 6/10/2026 |
| Ye Weiguo | ▲ Buy | Option Exercise | 5,000 | $4K | 6/10/2026 |
| Ye Weiguo | ▼ Sell | Open Market | 5,000 | $31K | 6/10/2026 |
| Ye Weiguo | ▼ Sell | Open Market | 14,500 | $89K | 6/9/2026 |
| Ye Weiguo | ▲ Buy | Option Exercise | 14,500 | $11K | 6/9/2026 |
| Ye Weiguo | ▲ Buy | Option Exercise | 3,000 | $2K | 6/9/2026 |
| Ye Weiguo | ▼ Sell | Open Market | 3,000 | $18K | 6/9/2026 |
| Ye Weiguo | ▲ Buy | Option Exercise | 15,401 | $12K | 6/5/2026 |
| Ye Weiguo | ▼ Sell | Open Market | 15,401 | $99K | 6/5/2026 |
| Ye Weiguo | ▲ Buy | Option Exercise | 19,575 | $15K | 6/4/2026 |
| Ye Weiguo | ▼ Sell | Open Market | 19,575 | $120K | 6/4/2026 |
| Ye Weiguo | ▼ Sell | Open Market | 4,000 | $24K | 5/26/2026 |
| Ye Weiguo | ▲ Buy | Option Exercise | 4,000 | $3K | 5/26/2026 |
| Ye Weiguo | ▲ Buy | Option Exercise | 3,500 | $3K | 5/22/2026 |
| Ye Weiguo | ▼ Sell | Open Market | 3,500 | $21K | 5/22/2026 |
| Ye Weiguo | ▼ Sell | Open Market | 12,820 | $79K | 5/21/2026 |
| Ye Weiguo | ▲ Buy | Option Exercise | 12,820 | $10K | 5/21/2026 |
| Ye Weiguo | ▲ Buy | Option Exercise | 9,400 | $7K | 5/20/2026 |
| Ye Weiguo | ▼ Sell | Open Market | 9,400 | $58K | 5/20/2026 |
| Ye Weiguo | ▲ Buy | Option Exercise | 9,120 | $7K | 5/19/2026 |
| Ye Weiguo | ▼ Sell | Open Market | 9,120 | $58K | 5/19/2026 |
| Ye Weiguo | ▲ Buy | Option Exercise | 200 | $150 | 5/18/2026 |
| Ye Weiguo | ▼ Sell | Open Market | 200 | $1K | 5/18/2026 |
| Ye Weiguo | ▲ Buy | Option Exercise | 13,100 | $10K | 5/15/2026 |
| Ye Weiguo | ▼ Sell | Open Market | 13,100 | $87K | 5/15/2026 |
| Ye Weiguo | ▲ Buy | Option Exercise | 15,580 | $12K | 5/14/2026 |
| Ye Weiguo | ▼ Sell | Open Market | 15,580 | $108K | 5/14/2026 |
| Luo Ying | ▼ Sell | Open Market | 10,136 | $81K | 5/6/2026 |
| Luo Ying | ▼ Sell | Open Market | 179 | $1K | 5/5/2026 |
| Ma Songjiang | ▼ Sell | Open Market | 558 | $6K | 5/28/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $21K | 5/27/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 182 | $2K | 5/23/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $22K | 5/22/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $22K | 5/21/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $23K | 5/20/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $22K | 5/19/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $23K | 5/16/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $21K | 5/15/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 20 | $226 | 5/14/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $23K | 5/13/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $21K | 5/12/2025 |
| Eastling Thomas Wilson | ▲ Buy | Option Exercise | 15,000 | $104K | 4/16/2025 |
| Ye Weiguo | ▲ Buy | Option Exercise | 50,000 | $38K | 4/1/2025 |
| Ye Weiguo | ▲ Buy | Option Exercise | 150,000 | $113K | 3/27/2025 |
| Ye Weiguo | ▲ Buy | Option Exercise | 200,000 | $150K | 3/26/2025 |
| Ye Weiguo | ▲ Buy | Option Exercise | 300,000 | $225K | 3/24/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 174 | $2K | 3/21/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $20K | 3/20/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $20K | 3/19/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 242 | $2K | 3/18/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $24K | 3/17/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $25K | 3/14/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $24K | 3/13/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $23K | 3/12/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $23K | 3/11/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $20K | 3/10/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 53 | $691 | 3/7/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 1,906 | $19K | 3/7/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 41 | $498 | 3/7/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $22K | 3/6/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $22K | 3/5/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $22K | 3/4/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $22K | 3/3/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $23K | 2/28/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $23K | 2/27/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $23K | 2/26/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $23K | 2/25/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 1,813 | $19K | 2/24/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 187 | $2K | 2/24/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 1,818 | $22K | 2/21/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 182 | $2K | 2/21/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $25K | 2/20/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $25K | 2/19/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $25K | 2/18/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $24K | 2/14/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $23K | 2/13/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $23K | 2/12/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 1,878 | $22K | 2/11/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $24K | 2/10/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $24K | 2/7/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $26K | 2/6/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 1,980 | $25K | 2/5/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 20 | $257 | 2/5/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $23K | 2/4/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $23K | 2/3/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $23K | 1/31/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $23K | 1/30/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $23K | 1/29/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $23K | 1/28/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $22K | 1/27/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $22K | 1/24/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $21K | 1/23/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $21K | 1/22/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $22K | 1/21/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $21K | 1/17/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $21K | 1/16/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $22K | 1/15/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $21K | 1/14/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 56 | $566 | 1/13/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 1,057 | $11K | 1/10/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 1,275 | $13K | 1/7/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 941 | $10K | 1/6/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 1,167 | $13K | 1/3/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $25K | 1/2/2025 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $25K | 12/31/2024 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $25K | 12/30/2024 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $25K | 12/27/2024 |
| Ma Songjiang | ▼ Sell | Open Market | 1,644 | $21K | 12/26/2024 |
| Ma Songjiang | ▼ Sell | Open Market | 356 | $5K | 12/26/2024 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $24K | 12/24/2024 |
| Ma Songjiang | ▼ Sell | Open Market | 1,704 | $21K | 12/23/2024 |
| Ma Songjiang | ▼ Sell | Open Market | 296 | $4K | 12/23/2024 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $22K | 12/20/2024 |
| Ma Songjiang | ▼ Sell | Open Market | 2,000 | $22K | 12/19/2024 |
| Ma Songjiang | ▼ Sell | Open Market | 1,571 | $18K | 12/18/2024 |
| Ma Songjiang | ▼ Sell | Open Market | 429 | $5K | 12/18/2024 |
| Ma Songjiang | ▼ Sell | Open Market | 1,212 | $13K | 12/17/2024 |
| Ma Songjiang | ▼ Sell | Open Market | 788 | $9K | 12/17/2024 |
| USMAN NASSIM | ▲ Buy | Option Exercise | 3,452 | $24K | 6/28/2024 |
| USMAN NASSIM | ▼ Sell | Open Market | 3,452 | $41K | 6/28/2024 |
| USMAN NASSIM | ▲ Buy | Option Exercise | 20,000 | $139K | 5/1/2024 |
| USMAN NASSIM | ▼ Sell | Open Market | 5,000 | $75K | 5/1/2024 |
| USMAN NASSIM | ▼ Sell | Open Market | 100 | $2K | 5/1/2024 |
| USMAN NASSIM | ▼ Sell | Open Market | 14,900 | $207K | 5/1/2024 |
| USMAN NASSIM | ▲ Buy | Option Exercise | 20,000 | $139K | 4/1/2024 |
| USMAN NASSIM | ▼ Sell | Open Market | 20,000 | $323K | 4/1/2024 |
| USMAN NASSIM | ▲ Buy | Option Exercise | 20,000 | $139K | 3/15/2024 |
| USMAN NASSIM | ▼ Sell | Open Market | 20,000 | $345K | 3/15/2024 |
| Ma Songjiang | ▼ Sell | Open Market | 833 | $10K | 1/3/2024 |
| Luo Ying | ▼ Sell | Other | 2,840,376 | — | 10/30/2023 |
| GNI Group Ltd. | ▼ Sell | Other | 63,588,119 | — | 10/30/2023 |
| GNI Hong Kong Ltd | ▼ Sell | Other | 5,371,304 | — | 10/27/2023 |
| LAWLOR AUGUSTINE | ▼ Sell | Other | 24 | — | 8/31/2023 |
| LAWLOR AUGUSTINE | ▼ Sell | Other | 25 | — | 8/31/2023 |
| Hunt Andrea | ▼ Sell | Other | 28 | — | 8/31/2023 |
| GNI Group Ltd. | ▼ Sell | Other | 5,371 | — | 8/31/2023 |
| GNI Group Ltd. | ▼ Sell | Other | 895 | — | 8/31/2023 |
| USMAN NASSIM | ▼ Sell | Other | 8 | — | 8/31/2023 |
| USMAN NASSIM | ▼ Sell | Other | 1 | — | 8/31/2023 |
| Miller Seline E. | ▼ Sell | Other | 7 | — | 8/31/2023 |
| USMAN NASSIM | ▼ Sell | Other | 25 | — | 8/31/2023 |
| Miller Seline E. | ▲ Buy | Open Market | 3,250 | $2K | 8/9/2022 |
| Blouse Grant E. | ▲ Buy | Open Market | 3,250 | $2K | 8/9/2022 |
| USMAN NASSIM | ▲ Buy | Open Market | 3,250 | $2K | 8/9/2022 |
| Miller Seline E. | ▲ Buy | Open Market | 3,250 | $1K | 2/9/2022 |
| Blouse Grant E. | ▲ Buy | Open Market | 3,250 | $1K | 2/9/2022 |
| USMAN NASSIM | ▲ Buy | Open Market | 3,250 | $1K | 2/9/2022 |
| Hunt Andrea | ▲ Buy | Grant | 7,521 | $0 | 1/7/2022 |
| Ling Geoffrey M.D. | ▲ Buy | Grant | 12,855 | $0 | 1/7/2022 |
| Eddie Williams | ▲ Buy | Grant | 12,308 | $0 | 1/7/2022 |
| Eddie Williams | ▲ Buy | Grant | 2,980 | $0 | 10/1/2021 |
| Ling Geoffrey M.D. | ▲ Buy | Grant | 2,858 | $0 | 10/1/2021 |
| LAWLOR AUGUSTINE | ▲ Buy | Grant | 5,839 | $0 | 10/1/2021 |
| Hunt Andrea | ▲ Buy | Grant | 1,824 | $0 | 10/1/2021 |
| Errol B. Desouza | ▲ Buy | Grant | 3,588 | $0 | 10/1/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
Gyre Therapeutics Schedules Investor Meetings for September
Gyre Therapeutics has announced participation in upcoming investor conferences scheduled for September. The company will engage with institutional investors and analysts through these scheduled meetings. Shares are currently trading near established support at $6.32, within a 52-week range of $5.44 to $9.42. Three analysts currently maintain an average price target of $18.67.
Gyre Therapeutics Schedules Investor Meetings for September. Gyre Therapeutics has announced participation in upcoming investor conferences scheduled for September. The company will engage with institutional investors and analysts through these scheduled meetings. Shares are currently trading near established support at $6.32, within a 52-week range of $5.44 to $9.42. Three analysts currently maintain an average price target of $18.67.